← Back to Clinical Trials
Recruiting NCT05057676

NCT05057676 Autoimmune Intervention Mastery Course Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05057676
Status Recruiting
Phase
Sponsor Terry L. Wahls
Condition Multiple Sclerosis
Study Type INTERVENTIONAL
Enrollment 400 participants
Start Date 2021-12-01
Primary Completion 2027-12-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 100 Years
Study Type INTERVENTIONAL
Interventions
Immediate Autoimmune Intervention Mastery Course (AIM)Immediate Question and Answer sessions. (AIM Q and A sessions)Delayed Autoimmune Intervention Mastery Course (delayed AIM course)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 400 participants in total. It began in 2021-12-01 with a primary completion date of 2027-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this project is to critically evaluate the effectiveness of using an online program to improve diet and self-care in patients with multiple sclerosis (MS), clinically isolated syndrome (CIS), fibromyalgia, post acute sequela of covid, and cancer in remission with persisting fatigue.

Eligibility Criteria

Inclusion Criteria: * self-reported multiple sclerosis * self-reported clinically isolated syndrome OR self-reported post-acute sequelae of COVID (PASC), also known as long COVID, with a confirmed laboratory test of COVID-19 infection, persisting fatigue and neuropsychiatric symptoms for longer than 6 months after confirmation of COVID diagnosis, OR self-reported diagnosis of fibromyalgia as documented by their treating specialist or primary care provider, Exclusion Criteria: \-

Contact & Investigator

Central Contact

Study Coordinator

✉ MSDietStudy@healthcare.uiowa.edu

📞 3193845002

Principal Investigator

Terry L Wahls, MD

PRINCIPAL INVESTIGATOR

University of Iowa

Frequently Asked Questions

Who can join the NCT05057676 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05057676 currently recruiting?

Yes, NCT05057676 is actively recruiting participants. Contact the research team at MSDietStudy@healthcare.uiowa.edu for enrollment information.

Where is the NCT05057676 trial being conducted?

This trial is being conducted at Iowa City, United States.

Who is sponsoring the NCT05057676 clinical trial?

NCT05057676 is sponsored by Terry L. Wahls. The principal investigator is Terry L Wahls, MD at University of Iowa. The trial plans to enroll 400 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology